Scientist, Statistical Programming, Early-Stage Oncology (Hybrid)
MSD
Summary
In BARDS (Biostatistics and Research Decision Sciences), quantitative scientists apply state-of-the-art scientific methodologies and tools to enable the discovery, development, regulatory approval, manufacturing, and marketing of medical drugs and vaccines. This position supports statistical programming activities for early-stage oncology clinical development projects.
Job description
Primary Activities
- Programmatically develop, validate and maintain efficacy and safety datasets, tables, listings, and figures at a protocol level
- Assure deliverable quality and compliance with departmental SOPs and good programming practices
- Collaborate effectively with project team members including outsource provider staff
Education and Minimum Requirement
- BA/BS in Computer Science, Statistics, Applied Mathematics, Life Sciences, Engineering or related field plus a minimum of 2 years SAS programming experience in a clinical trial environment
- MS in Computer Science, Statistics, Applied Mathematics, Life Sciences, Engineering or related field
- R programming is highly preferred
Department Required Skills and Experience
- Good interpersonal skills and ability to negotiate and collaborate effectively
- Good written, oral, and presentation skills
- Knowledge and experience in developing analysis and reporting deliverables for R&D projects (data, analyses, tables, graphics, listings)
- Takes direction effectively and completes tasks at a project level; ability to collaborate with key stakeholders
Position Specific Required Skills and Experience
- SAS programming experience including data steps, procedures, SAS/MACRO, SAS/GRAPH
- Ability to quickly and effectively learn new program techniques and data structures
- Takes direction effectively and completes programming tasks under the guidance of a senior programmer at a project level
- Knowledge in CDISC SDTM and ADaM standards
- An interest to advance career by investing in development activities and taking on tasks with increasing levels of challenge and responsibility
Preferred Skills and Experience
- R programming experience, including data derivation and analysis is highly preferred
- Knowledge of pharmaceutical development processes and clinical endpoint data (efficacy and safety)
- Unix operating system experience; systems and database experience
- Good working knowledge of reporting processes (SOPs) and software development life cycle
Requirements
- BA/BS in Computer Science, Statistics, Applied Mathematics, Life Sciences, Engineering or related field plus a minimum of 2 years SAS programming experience in a clinical trial environment
- MS in Computer Science, Statistics, Applied Mathematics, Life Sciences, Engineering or related field
- Good interpersonal skills and ability to negotiate and collaborate effectively
- Good written, oral, and presentation skills
- Knowledge and experience in developing analysis and reporting deliverables for R&D projects (data, analyses, tables, graphics, listings)
- Takes direction effectively and completes tasks at a project level; ability to collaborate with key stakeholders
- SAS programming experience including data steps, procedures, SAS/MACRO, SAS/GRAPH
- Ability to quickly and effectively learn new program techniques and data structures
- Knowledge in CDISC SDTM and ADaM standards
- R programming experience, including data derivation and analysis is highly preferred
- Knowledge of pharmaceutical development processes and clinical endpoint data (efficacy and safety)
- Unix operating system experience; systems and database experience
- Good working knowledge of reporting processes (SOPs) and software development life cycle
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Retirement Benefits
- Paid Holidays
- Vacation
- Sick & Compassionate Days
- Annual Bonus
- Long-Term Incentive
Company overview
MSD, known as Merck Sharp & Dohme outside the United States and Canada, is a global research-intensive biopharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891, the company has established itself as one of the world's leading pharmaceutical corporations with a rich history spanning over 130 years. MSD operates as the international division of Merck & Co., Inc., focusing on the discovery, development, manufacturing, and marketing of innovative medicines, vaccines, biologic therapies, and animal health products. The company's extensive portfolio includes groundbreaking treatments in oncology, infectious diseases, cardiology, diabetes, and vaccines, with notable products such as Keytruda (pembrolizumab) for cancer immunotherapy, Gardasil for HPV prevention, and Januvia for diabetes management. MSD maintains a strong commitment to research and development, investing significantly in scientific innovation to address unmet medical needs worldwide. With approximately 75,000 employees globally, the company operates through four main segments: pharmaceuticals, animal health, healthcare services, and strategic alliances. MSD's mission centers on using leading-edge science to save and improve lives around the world, guided by the principle that medicine is for people, not profits.